| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From The Larry A. Donoso Laboratory for Eye Research, University of Nottingham Division of Ophthalmology and Visual Sciences, Eye, Ear, Nose, and Throat Centre, University Hospital, Nottingham, United Kingdom.
PURPOSE. Antimicrobial peptides are the eukaryotic analogues of antibiotics. In addition to their antimicrobial activity, these peptides can signal to host cells and are therefore intermediaries between the innate and adaptive immune systems. Results in a prior study showed that ß-defensins-1 and -2 are made by ocular surface epithelial cells. In the present study, a survey was made of antimicrobial peptide expression, including 17 previously described members of the ß-defensin family, at the surface of the human eye.
METHODS. Total RNA was obtained from 43 fresh and cultured corneal and conjunctival samples, including 9 samples from patients with clinical infections. The expression of 21 antimicrobial peptides was determined using reverse transcription-PCR. Where detected, relative expression was quantitated using real-time PCR.
RESULTS. Expression of 7 of the 21 antimicrobial peptides investigated, ß-defensin-1 to -4, liver expressed antimicrobial peptide (LEAP)-1 and -2, and LL37/cathelicidin, were detected frequently in samples of ocular surface epithelia. Distinct but overlapping profiles of expression were detected in cornea and conjunctiva, with expression of ß-defensin-3 and -4 and LEAP1 and -2 most common in cultured corneal epithelia. Expression of ß-defensin-3 was detected in a greater percentage of corneal and conjunctival samples with infection.
CONCLUSIONS. Together with known lacrimal antimicrobial activities, these results extend the knowledge of antimicrobial activity at an important mucosal site, the ocular surface, allowing synergistic interactions to be investigated. The findings has significant implications both for the understanding of the normal homeostasis of mucosal surfaces and for antimicrobial and anti-inflammatory therapies.
This article has been cited by other articles:
|
|
 |
|
  P. Karicherla and J. A. Hobden Nona-D-Arginine Therapy for Pseudomonas aeruginosa Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 256 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Kojima, M Ueta, J Hamuro, Y Hozono, S Kawasaki, N Yokoi, and S Kinoshita Human conjunctival epithelial cells express functional Toll-like receptor 5 Br. J. Ophthalmol., March 1, 2008; 92(3): 411 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Abedin, I. Mohammed, A. Hopkinson, and H. S. Dua A Novel Antimicrobial Peptide on the Ocular Surface Shows Decreased Expression in Inflammation and Infection Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Brandt, R. Akkarawongsa, S. Altmann, G. Jose, A. W. Kolb, A. J. Waring, and R. I. Lehrer Evaluation of a {theta}-Defensin in a Murine Model of Herpes Simplex Virus Type 1 Keratitis Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5118 - 5124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hopkinson, R. S. McIntosh, P. J. Tighe, D. K. James, and H. S. Dua Amniotic Membrane for Ocular Surface Reconstruction: Donor Variations and the Effect of Handling on TGF-{beta} Content. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4316 - 4322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Huang, T. D. Petkova, R. Y. Reins, R. J. Proske, and A. M. McDermott Multifunctional Roles of Human Cathelicidin (LL-37) at the Ocular Surface. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2369 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Rodriguez-Martinez, M E Cancino-Diaz, and J C Cancino-Diaz Expression of CRAMP via PGN-TLR-2 and of {alpha}-defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts. Br. J. Ophthalmol., March 1, 2006; 90(3): 378 - 382. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
